Furukawa Hiroshi, Ohkado Akihiko, Nagashima Mitsugi, Ohsawa Hiroshi, Ichikawa Sei-ichi
Department of Cardiovascular Surgery, Cardiovascular Center, Okayama Central Hospital, Okayama, Japan.
Kyobu Geka. 2013 Aug;66(9):775-83.
We retrospectively evaluated the initial clinical experience of intraoperative cardiac output measurement by a new arterial pressure-based cardiac output (APCO:FloTrac/Vigileo) analysis in patients undergoing open heart surgery. Thirty-two patients (mean age 76.4, range 59 to 90)who underwent cardiac surgery under cardiopulmonary bypass( CPB) from July 2008 to September 2009 in our institute were enrolled in this study. There were 14 women and 18 men. The cardiac operations included 28 valve surgeries and 4 coronary artery bypass grafting. The APCO was introduced initially, then a continuous cardiac output (CCO:Swan-Ganz catheter) analysis system was established following the induction of anesthesia. The correlation of both cardiac output measurements was evaluated at 5 time points, T1:induction of anesthesia, T2:sternotomy, T3:after weaning from CPB, T4:closure of the chest, and T5:arrival at intensive care unit. There were no serious complications related to APCO and CCO. The correlation between APCO and CCO was evaluated by Bland-Altman plot analysis. The percentages of correlation between both groups were T1:81.2%, T2:78.1%, T3:59.4%, T4:62.5%, and T5:65.6%. A good correlation was shown in all 6 patients with atrial fibrillation at T1 and T2. No correlation was shown in the 3 patients with left ventricular( LV) dysfunction below LVEF 40%, 1 case at T3, all 3 cases at T4, and 2 cases at T5. Before the institution of CPB, 3 of the 6 at T1 and 3 of the 7 at T2 in whom no correlation was shown, had severe aortic valve insufficiency (AVI).From these results, APCO appears to be an acceptable device to evaluate the intraoperative cardiac output measurement compared with CCO, except in patients with LV dysfunction or AVI at some time points. Further studies will be necessary to elucidate the precise clinical evidence to assess the efficacy of this new analysis device.
我们回顾性评估了一种基于动脉压的心输出量(APCO:FloTrac/Vigileo)分析技术在心脏直视手术患者中进行术中心输出量测量的初步临床经验。本研究纳入了2008年7月至2009年9月在我院接受体外循环(CPB)心脏手术的32例患者(平均年龄76.4岁,范围59至90岁)。其中女性14例,男性18例。心脏手术包括28例瓣膜手术和4例冠状动脉旁路移植术。首先引入APCO,然后在麻醉诱导后建立连续心输出量(CCO: Swan-Ganz导管)分析系统。在5个时间点评估两种心输出量测量方法的相关性,T1:麻醉诱导时,T2:胸骨切开时,T3:CPB脱机后,T4:关胸时,T5:到达重症监护病房时。未发生与APCO和CCO相关的严重并发症。通过Bland-Altman图分析评估APCO与CCO之间的相关性。两组之间的相关性百分比分别为T1:81.2%,T2:78.1%,T3:59.4%,T4:62.5%,T5:65.6%。所有6例心房颤动患者在T1和T2时显示出良好的相关性。3例左心室(LV)功能障碍且左心室射血分数(LVEF)低于40%的患者中,1例在T3时、3例在T4时以及2例在T5时均未显示出相关性。在CPB开始前,T1时6例中有3例、T2时7例中有3例未显示出相关性,这些患者存在严重主动脉瓣关闭不全(AVI)。从这些结果来看,与CCO相比,除了在某些时间点存在LV功能障碍或AVI的患者外,APCO似乎是一种可接受的用于评估术中心输出量测量的设备。有必要进行进一步研究以阐明评估这种新分析设备疗效的确切临床证据。